Abstract:Abstract Background Recent studies highlight the role of interplay between oxidative stress, gut microbiota, and immune response in the etiology of Crohn’s disease (CD). Polyphenols are natural antioxidants which are mainly metabolized by gut microbiota and could modulate the composition of gut microbiota. However, it’s yet reported whether there is difference in polyphenol-degradation capacity of gut microbiota in CD and healthy controls (HCs). Methods A comprehensive literature search was conducted on microbial metabolic pathway of polyphenols and the responsible organisms and genes were recorded. The polyphenol-degrading genes were quantified using shortBRED in three clinical cohorts (the First Affiliated Hospital of Sun Yat-sen University (FAH) cohort, PRISM cohort, and HMP2 cohort). Microbiota abundance was analyzed in FAH and PRISM cohort. Polyphenol intake and serum metabolites were assessed in the FAH cohort. Enterotype analysis was performed in FAH cohort. Correlation analysis among polyphenol intake, gene abundance, serum metabolites and bacterial abundance was conducted. Results Phylogenetic tree revealed that reported polyphenol-degrading bacteria were mainly distributed to Actinobacteria and Firmicutes. The abundance of flavonoid degradation related genes (mainly flavone reductase, chalcone isomerase and phloretin hydrolase) was significantly decreased in patients with CD in FAH cohort, but not in PRISM and HMP cohort. Difference in abundance of polyphenol-degrading bacteria was observed between CD patients and HCs in FAH and PRISM cohort. In addition, lower polyphenols intake and serum hippuric acid (HA) level were detected in CD patients. Enterotype analysis revealed that CD patients were mainly distributed to Enterobacteriaceae- and Bacteroidaceae-dominated enterotype while HCs were mainly distributed to Ruminococcaceae- and Prevotellaceae-dominated enterotype. Serum HA level was higher in healthier enterotypes (Ruminococcaceae and Prevotellaceae dominant) and positively correlated with flavonoid-degrading organisms and butyric acid-producing organisms. No positive correlation between abundance of polyphenol-degradation genes and polyphenols intake was detected. Conclusion The current study summarized the polyphenol metabolic pathway mediated by gut microbiota and quantified genes responsible for polyphenol degradation. Our comprehensive analysis of diet-microbiota-gene-metabolite data revealed a lower capability of flavonoid degradation in gut microbiota and lower HA level in CD patients. Finally, our findings provide a foundation for future work exploring the polyphenol or polyphenol-degrading microbiota interventions in preclinical models of CD.

Excretion by subjects on a low (poly)phenol diet of phenolic gut microbiota catabolites sequestered in tissues or associated with catecholamines and surplus amino acids

Exploring and disentangling the production of potentially bioactive phenolic catabolites from dietary (poly)phenols, phenylalanine, tyrosine and catecholamines

Bioavailability of mango (poly)phenols: An evaluation of the impact of the colon, and phenylalanine and tyrosine on the production of phenolic catabolites

Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study

Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women

Identification of Phenolic Compounds-Rich Grape Pomace Extracts Urine Metabolites and Correlation with Gut Microbiota Modulation

Main drivers of (poly)phenol effects on human health: metabolite production and/or gut microbiota-associated metabotypes?

P1227 Revealing lower capacity of microbial metabolism of flavonoids and associated metabolic changes in Crohn’s disease

Dietary polyphenols maintain homeostasis <i>via</i> regulating bile acid metabolism: a review of possible mechanisms

Relationships between Habitual Polyphenol Consumption and Gut Microbiota in the INCLD Health Cohort

Gastrointestinal digestion of yerba mate, rosemary and green tea extracts and their subsequent colonic fermentation by human, pig or rat inocula

Dietary xenobiotics, (poly)phenols and fibers: Exploring associations with gut microbiota in socially vulnerable individuals

Ulcerative colitis results in differential metabolism of cranberry polyphenols by the colon microbiome in vitro

Optimization of GC/TOF MS Analysis Conditions for Assessing Host-Gut Microbiota Metabolic Interactions: Chinese Rhubarb Alters Fecal Aromatic Amino Acids and Phenol Metabolism.

A critical examination of human data for the biological activity of phenolic acids and their phase-2 conjugates derived from dietary (poly)phenols, phenylalanine, tyrosine and catecholamines

Fine-scale Dietary Polyphenol Intake is Associated with Systemic and Gastrointestinal Inflammation in Healthy Adults

Plant-Derived (Poly)phenols and Their Metabolic Outcomes: The Pursuit of a Role for the Gut Microbiota

Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity

Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products

Fecal excretion kinetics provides further support for polyphenols targeting microbiota: An example with prebiotic-like phlorizin

Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites